Compounding expert, Eric S. Kastango, BS Pharm, MBA, FASHP, discusses the strategies required for a robust hazardous drug safety program.
He addresses your pharmacy’s plan for proper work practices related to material handling, use of personal protective equipment (PPE), use of containment primary and secondary engineering controls (C-PECs and C-SECs), and considerations for the use of supplemental engineering controls, commonly known as closed-system drug transfer devices (CSTDs).
Discover the following:
- Key elements of compliance with USP Chapter <800> and the resources to achieve that compliance.
- The role and responsibilities of the designated person, as described in the chapter.
- A strategy to conduct an Assessment of Risk for those drugs listed on Table 2 and 3 of the NIOSH List.
